Smoldering myocarditis following immune checkpoint blockade

Smoldering myocarditis following immune checkpoint blockade

Abstract Background Severe myocarditis associated with electrical conduction abnormalities and occasionally heart failure has been well documented following treatment with immune checkpoint blockade with an estimated incidence of less than 1%. However, the incidence, early detection, and management...

Full description

Bibliographic Details
Main Authors: Timothy G. Norwood, Brian C. Westbrook, Douglas B. Johnson, Silvio H. Litovsky, Nina L. Terry, Svetlana B. McKee, Alan S. Gertler, Javid J. Moslehi, Robert M. Conry
Format: Article
Language:English
Published: BMJ Publishing Group 2017-11-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
Myocarditis
Cardiotoxicity
Immune checkpoint blockade
Nivolumab
Ipilimumab
Melanoma
Online Access:http://link.springer.com/article/10.1186/s40425-017-0296-4

Internet

http://link.springer.com/article/10.1186/s40425-017-0296-4

Similar Items